PeakBridge's FoodSparks Fund Backs Four Trailblazing Food and Health Startups
PeakBridge has unveiled four new seed-stage investments through its FoodSparks fund. The fund, launched in 2021 with EIT Food, supports innovative food and health startups across Europe. Each selected company aligns with strict criteria, including technology focus and regional presence.
The latest investments span plant-based dairy, functional ingredients, and gut health solutions. These startups join a growing portfolio backed by the €30 million initiative. The FoodSparks fund was established in 2021 with a €30 million budget. It targets pan-European startups in five key areas: alternative proteins, functional ingredients, food tech, nutraceuticals, and sustainable packaging. Companies must meet specific requirements, such as domicile, technological innovation, and alignment with PeakBridge's mission.
Among the new investments is GanEden, a plant-based ice cream maker. The startup aims to disrupt the dairy-free market with novel formulations. Another recipient, KÄÄPÄ Biotech, specialises in functional mushroom extracts. Their ultrasound-assisted technology enhances ingredient quality and efficiency.
Evinature, a nutraceutical firm, also secured funding. Their flagship product, CurQD, is used in over 40 US medical centres to support patients with Inflammatory Bowel Disease. The company blends botanical knowledge with clinical research to develop gut health solutions.
The fourth investment went to SOUS, a commerce platform for chefs and culinary entrepreneurs. The platform helps professionals unlock new revenue streams by connecting them with broader markets.
PeakBridge's selection process ensures each startup meets high standards. The fund's focus remains on early-stage innovation with measurable impact in food and health sectors. These four startups now join the FoodSparks portfolio, each addressing distinct challenges in food and wellness. The fund's €30 million backing continues to drive growth in alternative proteins, functional ingredients, and clinical nutrition. Further investments are expected as the initiative expands its reach across Europe.
